Press release

September 2019

Scilex Holding Company Strengthens Board of Directors with Appointment of Two Highly Accomplished Pharmaceutical and Biotechnology Executives, Scott Whitcup, M.D. and Elizabeth Czerepak

September 30, 2019

PALO ALTO, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — Scilex Holding Company (Scilex) today announced that it appointed Scott M. Whitcup, M.D. as lead independent director to its Board of Directors in May of this year. Dr. Whitcup is founder and Chief Executive Officer of Akrivista, LLC and Whitecap Biosciences, LLC, two companies focused on … Continue reading Scilex Holding Company Strengthens Board of Directors with Appointment of Two Highly Accomplished Pharmaceutical and Biotechnology Executives, Scott Whitcup, M.D. and Elizabeth Czerepak

Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

September 23, 2019

SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) — Scilex Holding Company (Scilex), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE), announced that it has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to its proposed initial public offering of its common stock. The … Continue reading Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
X

Share This Page

XS SM MD LG XL